-
Korean Researchers Advance Peptide Eye Drops as Needle-Free Alternative for Macular Degeneration
South Korean scientists are developing peptide-based eye drops designed to treat macular degeneration without the need for repeated injections into the eye. The approach could offer patients a more comfortable, accessible treatment option.
-
New Structural Insights into Alzheimer’s Peptide Could Guide Next-Generation Drugs
Yale researchers have gained a clearer view of the peptide implicated in Alzheimer’s disease, offering new possibilities for designing more effective treatments. The findings could help scientists create drugs that target the disease more precisely.
-
Elysium Health Expands Into Peptides as Regulatory Pathway Eases
Elysium Health is broadening its product portfolio into peptides, following regulatory adjustments from HHS that simplify compounding pathways for these promising compounds. The move signals growing mainstream confidence in peptide-based wellness offerings.
-
Regulatory Shift Signals Growing Opportunity for Peptides in Dietary Supplements
A new enforcement discretion approach from regulators is expected to open the door for broader use of certain peptides in the dietary supplement industry, signaling potential growth and innovation ahead.
-
Elysium Health Broadens Peptide Access with Six New Offerings Under Updated HHS Policy
Elysium Health has expanded its peptide lineup by six additional compounds following a new HHS policy update, while also launching dedicated peptide research programs to support further study.
-
Amble Health Expands Access to Compounded Peptides via Telehealth Platform
Amble Health has introduced six compounded peptide options through its online medical care platform, making it easier for patients to access peptide-based care with physician oversight from the comfort of home.
-
Glucagon-Like Peptide Agonist Pipeline Continues to Expand
Industry analysis points to a growing number of clinical trials exploring glucagon-like peptide (GLP) agonists, reflecting sustained momentum in this promising area of peptide-based therapeutics.
-
Novel Antimicrobial Peptide Shows Promise Against Drug-Resistant Pneumonia
Researchers have identified an antimicrobial peptide that may offer a new therapeutic approach for bacterial pneumonia while helping to address the growing challenge of antimicrobial resistance. The findings, published in Nature, point to a promising avenue for future treatment development.
-
The Rise of Clinician-Guided Peptide Care: A Safer Path Forward
A growing trend highlights the importance of clinician oversight in peptide therapy, emphasizing safety, personalization, and professional guidance over self-administration.
-
The Quest for Swallowable Peptides: Innovators Push Toward Oral Delivery Breakthroughs
Scientists and drug developers are making steady progress on one of peptide medicine’s biggest challenges: creating effective oral tablets instead of injections. New formulation strategies are bringing this goal closer to reality.